Musa balbisiana (Musa balbisiana): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Musa balbisiana work as an astringent for diarrhea?

Musa balbisiana contains tannins, saponins, and flavonoids that provide its medicinal effects. The tannins are primarily responsible for the astringent action—they bind to proteins in the mucous membranes of the digestive tract, creating a protective layer that reduces inflammation and fluid secretion. This astringent effect helps firm stools and reduce diarrhea frequency. The herb's anti-inflammatory compounds may also contribute to soothing irritated digestive tissues. Evidence level: C (preliminary/traditional use).

Does Musa balbisiana interact with any medications?

Musa balbisiana contains significant tannin content, which may bind to certain medications in the digestive tract and reduce their absorption. This could potentially affect the effectiveness of oral medications taken concurrently. To minimize this risk, separate consumption of Musa balbisiana products from prescription medications by at least 2 hours. No specific clinical drug interaction studies exist for this herb. Consult a healthcare provider before combining with prescription medications. Evidence level: C.

What is the recommended dosage for Musa balbisiana?

Traditional preparations of Musa balbisiana typically use unripe fruit consumed as food, or dried leaf prepared as a tea at approximately 2 grams per cup. For digestive support, the astringent fruit may be consumed 1-2 times daily. No standardized clinical dosing guidelines exist, as most evidence derives from traditional use rather than clinical trials. Start with lower doses to assess tolerance. Consult a qualified herbalist or healthcare provider for personalized recommendations. Evidence level: Traditional/C.

Is Musa balbisiana safe during pregnancy and breastfeeding?

Musa balbisiana is considered unsafe during pregnancy and should be avoided. The herb's strong astringent properties and active compounds, including tannins and saponins, may stimulate uterine contractions or affect fetal development. Traditional use contraindicates this herb for pregnant women. Safety during breastfeeding has not been established. Additionally, individuals with latex allergy should avoid Musa balbisiana due to potential cross-reactivity, as bananas belong to a plant family known to cause reactions in sensitive individuals. Evidence level: C/Traditional.

What are the side effects of Musa balbisiana?

Musa balbisiana may cause mild adverse reactions in some individuals, primarily gastrointestinal discomfort or mild allergic responses. People with latex allergy face increased risk of cross-reactive allergic reactions and should avoid this herb entirely. The high tannin content may cause constipation if consumed excessively. No serious adverse events have been documented in traditional use records, though comprehensive safety studies are lacking. Discontinue use if any adverse symptoms develop and consult a healthcare provider. Evidence level: C.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Musa balbisiana is a wild-type diploid banana species and progenitor of many modern cultivars, recognized for its resistance to various plant pathogens [PMID: 24091289, 35408979]. Recent studies indicate it possesses potential antidiabetic, anti-inflammatory, and antimicrobial properties [PMID: 33234097, 37693819, 40735398].

Background

Musa balbisiana is a wild-type banana species endemic to Southern China, Eastern South Asia, and Northern Southeast Asia [PMID: 33490514]. It serves as one of the two primary ancestral parents (B-genome) of many modern parthenocarpic banana and plantain cultivars [PMID: 24091289, 31308504].

Traditional uses

Different parts of M. balbisiana have been used widely in traditional medicine to treat many disorders [PMID: 39723093].

Active compounds

The plant contains flavonoids, saponins, and triterpenoids [PMID: 37518917]. Specific phytochemicals identified in peel extracts include trigonelline and vanillin [PMID: 37693819], while fruit-derived wine contains volatile compounds such as butan-1-ol, propanoic acid, 2-phenylethanol, and oxolane-2,5-dione [PMID: 39279595].

Mechanism of action

M. balbisiana exhibits antidiabetic activity through the inhibition of α-amylase and α-glucosidase enzymes [PMID: 33234097, 39723093]. Its anti-inflammatory effects are associated with flavonoid compounds [PMID: 37518917, 39308702]. In terms of plant defense, it activates PAMP-triggered basal defense and disease resistance (R) protein-mediated defense against pathogens [PMID: 31065041].

Clinical evidence

Evidence DAcne Vulgaris

Musa balbisiana peel extract (MBPE) demonstrated protective effects against acne vulgaris in rats, reducing nodule size and cytokine levels (IL-1α, IFN-γ, TNF-α, and IL-8) [PMID: 37693819]

Evidence DType 2 Diabetes / Hyperglycemia

Various parts (seed, fruit, corm, inflorescence) inhibit α-amylase and α-glucosidase; seeds specifically effectively lowered the blood glucose index in alloxan-induced mice [PMID: 39723093, 30393852]

Evidence DInflammation

Ethanol extract gel of Kepok banana peel showed significant anti-inflammatory effects in rats induced with carrageenan [PMID: 37518917]

Evidence DPhotoaging

Transfersome gel of M. balbisiana peel showed ameliorative effects against UVB-induced photoaging in Wistar rat skin [PMID: 39308702]

Evidence DBacterial/Fungal Infections

M. balbisiana parts exhibit antibacterial activity (more effective against positive-gram bacteria like S. aureus and B. subtilis) and antifungal activity against A. niger and A. flavus, with seeds showing the strongest effect [PMID: 40735398]

Safety & adverse effects

The fruits of M. balbisiana were found to contain a negligible amount of toxic elements [PMID: 33234097].

Evidence summary

The current evidence is based on in vitro assays and in vivo animal models (rats/mice), representing a low level of clinical evidence (Level D). No human clinical trials were provided.

PubMed sources

1.PMID: 36633389 (2023) — Resistance of Musa balbisiana Accessions of the Philippines to Banana Bunchy Top Virus. · Plant disease
2.PMID: 32940596 (2020) — ICTV Virus Taxonomy Profile: Caulimoviridae. · The Journal of general virology
3.PMID: 37921458 (2023) — Endophytic bacteria associated with wild-type banana seed (Musa balbisiana): whole genome sequencing. · Microbiology resource announcements
4.PMID: 37693819 (2023) — Anti-inflammatory effects of banana (Musa balbisiana) peel extract on acne vulgaris: In vivo and in silico study. · Journal of Taibah University Medical Sciences
5.PMID: 33490514 (2018) — The complete chloroplast genome sequence of wild banana, Musa balbisiana variety 'Pisang Klutuk Wulung' (Musaceae). · Mitochondrial DNA. Part B, Resources

Musa balbisiana

Sources & Citations

Calculate a safe dose of Musa balbisiana

Vasconcellea quercifolia

Entada Seed

Centaury European

Frequently asked questions

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources

Musa balbisiana

Sources & Citations

Calculate a safe dose of Musa balbisiana

Related Herbs

Vasconcellea quercifolia

Entada Seed

Centaury European

Frequently asked questions

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources